DuLac Farmaceutici, the Italian wellness company known for its pharmaceutical heritage and recovery-focused dermocosmetic products, announced plans to expand its presence across the United States following continued growth through its Amazon U.S. storefront. The Boca Raton, Florida-based company aims to reach more consumers with products developed through decades of Italian pharmaceutical expertise.
Founded on more than 30 years of pharmaceutical industry experience, DuLac Farmaceutici has built a reputation in Europe for combining traditional botanical ingredients with advanced manufacturing technologies and pharmacy-first production standards. The company’s growing U.S. presence reflects increasing consumer demand for wellness and recovery products developed with pharmaceutical-grade precision, clean-label formulations, and ingredient traceability.
“At DuLac, our mission has always been to develop innovative and effective wellness solutions rooted in both science and nature,” said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. “We are excited to continue expanding our presence in the United States and introduce more consumers to products developed through decades of Italian pharmaceutical expertise, advanced research, and high-quality manufacturing standards.”
DuLac’s portfolio includes recovery-focused dermocosmetic products, wellness solutions, and circulation-support formulations designed for active lifestyles, everyday comfort, and wellness-conscious consumers. Key products include the Arnica Gel 98% collection, Arnica Gel 98% Formula Complex recovery products, and vascular and microcirculation wellness solutions such as Diosmin 500 and Dinaven.
For its Arnica Gel 98% formulations, DuLac utilizes a vertically integrated “seed-to-shelf” production model designed to support phytocomplex consistency, traceability, and quality control across cultivation, extraction, formulation, and manufacturing. The company employs advanced technologies including supercritical CO₂ extraction and controlled-environment cultivation systems to preserve botanical integrity and consistency.
DuLac recently partnered with a state-of-the-art 2,500-square-meter research and manufacturing hub in Italy that combines AI-assisted formulation technology with pharmaceutical-grade production standards. The facility operates under GMP, ISO 22716, and ISO 9001 quality frameworks and supports the company’s growing international expansion efforts.
“Our goal is not simply to sell wellness products, but to elevate standards across the category,” added Bollani. “By combining pharmaceutical expertise, modern innovation, and carefully selected natural ingredients, we are building solutions designed around real consumer wellness needs.”
The company’s U.S. expansion strategy includes plans to increase awareness across additional retail, e-commerce, wellness, and recovery-focused distribution channels in the coming months. Consumers can currently explore DuLac Farmaceutici products through the company’s official U.S. Amazon storefront.
For business leaders, this expansion signals a growing trend of European pharmaceutical-heritage brands entering the U.S. wellness market with differentiated, science-backed products. DuLac’s emphasis on clean-label formulations and AI-assisted manufacturing may set new standards for quality and transparency in the wellness industry, potentially influencing competitors to adopt similar practices. The company’s vertical integration in arnica cultivation and extraction also highlights the importance of supply chain control in maintaining product consistency and consumer trust.
